← FDA DRUG APPROVALS
FDA ANDA · ANDA205743
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Sponsor: PAR PHARM INC
APPLICATION
ANDA205743
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
None (Tentative Approval)
Products
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATENone (Tentative Approval)
CITRIC ACID 12GM/PACKET, MAGNESIUM OXIDE 3.5GM/PACKET, SODIUM PICOSULFATE 10MG/PACKET · FOR SOLUTION · ORAL
Approval history
2016-11-21UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.